BIANCA SHUSTER: Open Payments
NPI 1942853957 · DERBY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 45 payments from 16 companies in 2025. Trend: 2023 $1,912 · 2024 $430 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $155 |
| Astellas Pharma US Inc | 5 | $134 |
| COLOPLAST CORP | 5 | $102 |
| UROGEN PHARMA, INC. | 3 | $66 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| IMMUNITYBIO, INC. | 2 | $53 |
| Ferring Pharmaceuticals Inc. | 3 | $53 |
| TOLMAR, INC. | 3 | $52 |
| Integra LifeSciences Corporation | 1 | $46 |
| ABBVIE INC. | 2 | $38 |
Products named: Veozah, Luja Coude, ORGOVYX, KEYTRUDA, GEMTESA, ANKTIVA, ADSTILADRIN, JATENZO.
Industry payments across CT — which companies pay providers there.
